Pöschke, P.; Fasching, P.A.; Adler, W.; Rübner, M.; Beckmann, M.W.; Hack, C.C.; Heindl, F.; Hartmann, A.; Erber, R.; Gass, P.
Clinical Characteristics and Prognosis of HER2-0 and HER2-Low-Positive Breast Cancer Patients: Real-World Data from Patients Treated with Neoadjuvant Chemotherapy. Cancers 2023, 15, 4678.
https://doi.org/10.3390/cancers15194678
AMA Style
Pöschke P, Fasching PA, Adler W, Rübner M, Beckmann MW, Hack CC, Heindl F, Hartmann A, Erber R, Gass P.
Clinical Characteristics and Prognosis of HER2-0 and HER2-Low-Positive Breast Cancer Patients: Real-World Data from Patients Treated with Neoadjuvant Chemotherapy. Cancers. 2023; 15(19):4678.
https://doi.org/10.3390/cancers15194678
Chicago/Turabian Style
Pöschke, Patrik, Peter A. Fasching, Werner Adler, Matthias Rübner, Matthias W. Beckmann, Carolin C. Hack, Felix Heindl, Arndt Hartmann, Ramona Erber, and Paul Gass.
2023. "Clinical Characteristics and Prognosis of HER2-0 and HER2-Low-Positive Breast Cancer Patients: Real-World Data from Patients Treated with Neoadjuvant Chemotherapy" Cancers 15, no. 19: 4678.
https://doi.org/10.3390/cancers15194678
APA Style
Pöschke, P., Fasching, P. A., Adler, W., Rübner, M., Beckmann, M. W., Hack, C. C., Heindl, F., Hartmann, A., Erber, R., & Gass, P.
(2023). Clinical Characteristics and Prognosis of HER2-0 and HER2-Low-Positive Breast Cancer Patients: Real-World Data from Patients Treated with Neoadjuvant Chemotherapy. Cancers, 15(19), 4678.
https://doi.org/10.3390/cancers15194678
